Last reviewed · How we verify

NCT02662153

Incidence and Predictors of Opioid Overdose and Death Among Long-Term Users of Opioid Analgesics

Completed Last updated 14 July 2022
What this trial tests

trial testing Observation only in Opioid Overdose in 808,455 participants. Completed in 30 June 2021.

Timeline
2 May 2019
Primary endpoint
30 June 2021
30 June 2021

Quick facts

Lead sponsorMember Companies of the Opioid PMR Consortium
StatusCompleted
Study typeOBSERVATIONAL
Enrollment808,455
Start date2 May 2019
Primary completion30 June 2021
Estimated completion30 June 2021
Sites4 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Member Companies of the Opioid PMR Consortium

Who can join

Adults 18 to 79, any sex, with Opioid Overdose. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Retrospective study to assess incidence and predictors of opioid abuse overdose and death associated with opioid overdose among patients prescribed opioid products in long-term use.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Observation only

Trials testing the same drug.

Other recruiting trials for Opioid Overdose

Currently open trials in the same condition.

Other Member Companies of the Opioid PMR Consortium trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02662153.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing